Goldman Sachs Group Inc Merrimack Pharmaceuticals Inc Transaction History

Goldman Sachs Group Inc

  • $580 Billion
  • Q2 2024

A detailed history of Goldman Sachs Group Inc transactions in Merrimack Pharmaceuticals Inc stock. As of the latest transaction made, Goldman Sachs Group Inc holds 29,807 shares of MACK stock, worth $450,979. This represents 0.0% of its overall portfolio holdings.

Number of Shares
29,807
Previous 14,471 105.98%
Holding current value
$450,979
Previous $213,000 111.27%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$14.68 - $15.13 $225,132 - $232,033
15,336 Added 105.98%
29,807 $450,000
Q1 2024

May 15, 2024
SELL
$13.06 - $15.0 $270,681 - $310,890
-20,726 Reduced 58.89%
14,471 $213,000
Q4 2023

Feb 13, 2024
BUY
$12.02 - $13.41 $2,932 - $3,272
244 Added 0.7%
35,197 $471,000
Q3 2023

May 14, 2024
SELL
$11.6 - $12.52 $2,830 - $3,054
-244 Reduced 0.69%
34,953 $430,000
Q3 2023

Nov 14, 2023
BUY
$11.6 - $12.52 $241,407 - $260,553
20,811 Added 147.16%
34,953 $430,000
Q2 2023

May 14, 2024
SELL
$12.02 - $13.07 $249,487 - $271,280
-20,756 Reduced 59.48%
14,142 $173,000
Q2 2023

Aug 14, 2023
SELL
$12.02 - $13.07 $249,487 - $271,280
-20,756 Reduced 59.48%
14,142 $173,000
Q1 2023

May 14, 2024
BUY
$11.35 - $12.32 $235,580 - $255,713
20,756 Added 146.77%
34,898 $428,000
Q1 2023

May 11, 2023
BUY
$11.35 - $12.32 $235,580 - $255,713
20,756 Added 146.77%
34,898 $428,000
Q4 2022

Feb 13, 2023
BUY
$3.68 - $12.51 $52,042 - $176,916
14,142 New
14,142 $162,000
Q2 2022

May 14, 2024
SELL
$4.89 - $7.13 $102,958 - $150,122
-21,055 Reduced 59.82%
14,142 $84,000
Q2 2022

Aug 15, 2022
BUY
$4.89 - $7.13 $69,154 - $100,832
14,142 New
14,142 $84,000

Others Institutions Holding MACK

# of Institutions
9
Shares Held
430K
Call Options Held
0
Put Options Held
0
View Full List

About MERRIMACK PHARMACEUTICALS INC

MACK Quotes by TradingView
  • Ticker MACK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,410,200
  • Market Cap $203M
  • Description
  • Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.
More about MACK
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email